Prognomix Inc - Product Pipeline Analysis, 2018 Update

  • ID: 4415726
  • Company Profile
  • 19 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Canada Diagnostic Centres
  • Eli Lilly Canada Inc
  • MORE
Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02. Its PGx CD01 is an in vitro molecular companion diagnostic product used for the treatment of cardiovascular and renal complications of type 2 diabetes. Prognomix’s PGX IR01 is an in vitro molecular predictive test used for assessing the risk of complications in patients with type 2 diabetes. The company also develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. Prognomix is headquartered in Montreal, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Prognomix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Canada Diagnostic Centres
  • Eli Lilly Canada Inc
  • MORE
  • Prognomix Inc Company Overview
  • Prognomix Inc Company Snapshot
  • Prognomix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Prognomix Inc - Pipeline Analysis Overview
  • Prognomix Inc - Key Facts
  • Prognomix Inc - Major Products and Services
  • Prognomix Inc Pipeline Products by Development Stage
  • Prognomix Inc Pipeline Products Overview
  • PGx CD01 Companion Diagnostic Test
  • PGx CD01 Companion Diagnostic Test Product Overview
  • PGx GR01
  • PGx GR01 Product Overview
  • PGx IR01
  • PGx IR01 Product Overview
  • PGx IR02
  • PGx IR02 Product Overview
  • Prognomix Inc - Key Competitors
  • Prognomix Inc - Key Employees
  • Prognomix Inc - Locations And Subsidiaries
  • Head Office
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Prognomix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Prognomix Inc Pipeline Products by Equipment Type
  • Prognomix Inc Pipeline Products by Indication
  • Prognomix Inc, Key Facts
  • Prognomix Inc, Major Products and Services
  • Prognomix Inc Number of Pipeline Products by Development Stage
  • Prognomix Inc Pipeline Products Summary by Development Stage
  • PGx CD01 Companion Diagnostic Test - Product Status
  • PGx CD01 Companion Diagnostic Test - Product Description
  • PGx GR01 - Product Status
  • PGx GR01 - Product Description
  • PGx IR01 - Product Status
  • PGx IR01 - Product Description
  • PGx IR02 - Product Status
  • PGx IR02 - Product Description
  • Prognomix Inc, Key Employees
  • Glossary
List of Figures
  • Prognomix Inc Pipeline Products by Equipment Type
  • Prognomix Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Canada Diagnostic Centres
  • KMH Cardiology & Diagnostic Centres, Inc.
  • Eli Lilly Canada Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll